BlueInvest and Bluebio Alliance are proud to announce an exclusive e-pitching session featuring 5 innovative projects in the Blue Biotechnology sector. Mark your calendars for Wednesday, April 17, 2024, at 4:00 PM CET.

PITCHING CANDIDATES:

AmpliAqua

Portugal

AmpliAqua presents a fully operational unit of an aquaponic system that aims to adopt sustainable and viable in-land aquaponics practices, addressing the pressing challenges faced by traditional fish farming. By integrating new solid waste management solutions, implementing cost-effective techniques to avoid fish flavor issues, and leveraging advanced IT tools, AmpliAqua sets the stage for a transformation in the aquaculture industry. 

Blue Skincare

France

BLUE SKINCARE®  introduces the first dermo-cosmetic brand offering restorative skincare routines based on a patented proprietary ingredients derived form mother-of-pearl Active-NACR45® and BIONACRE®

Women founder | Customers : 4000+ | TRL: 7 | CA 2021-2022: €350k | Serie A | Next step: Commercial Acceleration | B2B, B2B2C, B2C | €3.5M sought | France

Inclita Seaweed Solutions 

Portugal

Marine biotech company freeing the goodness from seaweed for the cosmetic and nutraceutical industries.

Women founder | Serie A | Next step: Industrialisation | B2B | €7.5M sought 

Microbia Environnement 

France

Microbia Environnement designs highly-sensitive genetic biosensors for the detection of active microorganisms in aquatic ecosystems. By targeting toxin-producing cyanobacteria and microalgae, this unique technology provides an advanced tool for early warning systems dedicated to harmful proliferations.

Women founder | Customers: 17 | TRL: 8 | TAM: €5B | SAM: €2.5B | Seed | Next step: Commercial Acceleration | B2B | €1M sought 

Relicta srl 

Italy

Production of packaging made from fish waste.

Partnering with companies like Amadori, Finpesca, Ghelfi, Plastigraf Trevigiana, and Repack to demonstrate the practical application of their bioplastic products. Relicta develops customised film reels that match their current packaging and conduct industrial trials to test performance. 

Women founder | TRL: 7 | TAM: $270B | SAM: $58B | Seed | Next step: Industrialisation | B2B | €2.2M